对山本等人所著《利妥昔单抗对IgG4相关疾病的长期疗效如何？利妥昔单抗治疗4年的病例经验》的回应 - Suppr

Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al.

作者信息

Stone John H, Carruthers Mollie N, Topazian Mark D, Khosroshahi Arezou, Witzig Thomas E, Wallace Zachary S, Hart Phillip A, Deshpande Vikram, Smyrk Thomas C, Chari Suresh

机构信息

Allergy and Immunology Division, Department of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Department of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.

出版信息

Ann Rheum Dis. 2015 Aug;74(8):e47. doi: 10.1136/annrheumdis-2015-207640. Epub 2015 Apr 28.

DOI:10.1136/annrheumdis-2015-207640

PMID:26160908

Abstract

摘要

相似文献

Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al.

Ann Rheum Dis. 2015 Aug;74(8):e47. doi: 10.1136/annrheumdis-2015-207640. Epub 2015 Apr 28.

Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years.

Ann Rheum Dis. 2015 Aug;74(8):e46. doi: 10.1136/annrheumdis-2015-207625. Epub 2015 Apr 10.

Rituximab for IgG4-related disease: a prospective, open-label trial.

Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605. Epub 2015 Feb 9.

Recurrence of IgG4-related disease following treatment with rituximab.

Mod Rheumatol. 2013 Nov;23(6):1226-30. doi: 10.1007/s10165-012-0738-2. Epub 2012 Sep 6.

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.

Arthritis Rheum. 2010 Jun;62(6):1755-62. doi: 10.1002/art.27435.

Update on rituximab.

Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv55-7. doi: 10.1136/ard.2005.042648.

Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience.

Rheumatol Int. 2013 Jun;33(6):1495-504. doi: 10.1007/s00296-012-2587-x. Epub 2012 Dec 14.

Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.

Am J Otolaryngol. 2012 Sep-Oct;33(5):619-22. doi: 10.1016/j.amjoto.2012.01.006. Epub 2012 Feb 21.

Central nervous system manifestation of IgG4-related disease.

JAMA Neurol. 2014 Jun;71(6):767-70. doi: 10.1001/jamaneurol.2014.40.

Rituximab for the Treatment of IgG4-Related Tubulointerstitial Nephritis: Case Report and Review of the Literature.

Medicine (Baltimore). 2015 Aug;94(32):e1366. doi: 10.1097/MD.0000000000001366.

引用本文的文献

Long-Term Outcomes of IgG4-Related Ophthalmic Disease in a Chinese IgG4-Related Disease Cohort.

Front Med (Lausanne). 2021 Dec 17;8:784520. doi: 10.3389/fmed.2021.784520. eCollection 2021.

Myocardial ischemia as presenting manifestation of IgG4-related disease: a case-based review.

Clin Rheumatol. 2016 Nov;35(11):2857-2864. doi: 10.1007/s10067-016-3292-z. Epub 2016 May 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al.

作者信息

Stone John H, Carruthers Mollie N, Topazian Mark D, Khosroshahi Arezou, Witzig Thomas E, Wallace Zachary S, Hart Phillip A, Deshpande Vikram, Smyrk Thomas C, Chari Suresh

机构信息

Allergy and Immunology Division, Department of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.

Department of Rheumatology, Massachusetts General Hospital, Boston, Massachusetts, USA.

出版信息

Ann Rheum Dis. 2015 Aug;74(8):e47. doi: 10.1136/annrheumdis-2015-207640. Epub 2015 Apr 28.

DOI:10.1136/annrheumdis-2015-207640

PMID:26160908

Abstract

摘要

相似文献

Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al.

Ann Rheum Dis. 2015 Aug;74(8):e47. doi: 10.1136/annrheumdis-2015-207640. Epub 2015 Apr 28.

Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years.

Ann Rheum Dis. 2015 Aug;74(8):e46. doi: 10.1136/annrheumdis-2015-207625. Epub 2015 Apr 10.

Rituximab for IgG4-related disease: a prospective, open-label trial.

Ann Rheum Dis. 2015 Jun;74(6):1171-7. doi: 10.1136/annrheumdis-2014-206605. Epub 2015 Feb 9.

Recurrence of IgG4-related disease following treatment with rituximab.

Mod Rheumatol. 2013 Nov;23(6):1226-30. doi: 10.1007/s10165-012-0738-2. Epub 2012 Sep 6.

Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.

Arthritis Rheum. 2010 Jun;62(6):1755-62. doi: 10.1002/art.27435.

Update on rituximab.

Ann Rheum Dis. 2005 Nov;64 Suppl 4(Suppl 4):iv55-7. doi: 10.1136/ard.2005.042648.

Rituximab: rescue therapy in life-threatening complications or refractory autoimmune diseases: a single center experience.

Rheumatol Int. 2013 Jun;33(6):1495-504. doi: 10.1007/s00296-012-2587-x. Epub 2012 Dec 14.

Use of intravenous immunoglobulin to treat chronic bilateral otomastoiditis in the setting of rituximab induced hypogammaglobulinemia.

Am J Otolaryngol. 2012 Sep-Oct;33(5):619-22. doi: 10.1016/j.amjoto.2012.01.006. Epub 2012 Feb 21.

Central nervous system manifestation of IgG4-related disease.

JAMA Neurol. 2014 Jun;71(6):767-70. doi: 10.1001/jamaneurol.2014.40.

Rituximab for the Treatment of IgG4-Related Tubulointerstitial Nephritis: Case Report and Review of the Literature.

Medicine (Baltimore). 2015 Aug;94(32):e1366. doi: 10.1097/MD.0000000000001366.

引用本文的文献

Long-Term Outcomes of IgG4-Related Ophthalmic Disease in a Chinese IgG4-Related Disease Cohort.

Front Med (Lausanne). 2021 Dec 17;8:784520. doi: 10.3389/fmed.2021.784520. eCollection 2021.

Myocardial ischemia as presenting manifestation of IgG4-related disease: a case-based review.

Clin Rheumatol. 2016 Nov;35(11):2857-2864. doi: 10.1007/s10067-016-3292-z. Epub 2016 May 4.

Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al.

作者信息

机构信息

出版信息

相似文献

引用本文的文献